Zobrazeno 1 - 10
of 192
pro vyhledávání: '"kayexalate"'
Publikováno v:
Indian Journal of Transplantation, Vol 18, Iss 3, Pp 317-320 (2024)
Reactive chemical gastropathy is also termed drug-induced gastropathy. The terms gastropathy and gastritis vary in their etiology ultimately causing mucosal injury. The gastric mucosa is different in different regions. The oxyntic mucosa is seen in t
Externí odkaz:
https://doaj.org/article/7ccd3068fddb4dba91657b8f21b38808
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2024)
IntroductionType 1 pseudohypoaldosteronism (PHA) consists of resistance to aldosterone. Neonatal presentation is characterized by salt wasting, hyperkalemia, and metabolic acidosis with high risk of mortality. Type 1 PHA can be autosomal dominant (re
Externí odkaz:
https://doaj.org/article/d1f2eb1a3ea64fb7b56d1caed631752e
Autor:
Julia Collot, Tayeb Salaouatchi, Fabienne Rickaert, Albino Floriani, Benoit Buysschaert, Maria Mesquita, Eric Godon
Publikováno v:
Clinical Case Reports, Vol 9, Iss 4, Pp 2385-2389 (2021)
Abstract Kayexalate can cause severe unrecognized GI lesions. Diagnosis of kayexalate crystals in GI biopsy samples is important. Pathologists and clinicians should work hand in hand. New drugs should be available to all patients to treat hyperkalemi
Externí odkaz:
https://doaj.org/article/0788549335484aa8a18ebb2ab4c1d995
Publikováno v:
Case Reports in Gastroenterology, Vol 15, Iss 3, Pp 885-890 (2021)
Kayexalate has been used in the USA since 1975 for the treatment of hyperkalemia. Prior case reports have shown that sorbitol added to kayexalate has been known to cause rare side effects of colonic necrosis. We present a unique case report of gastri
Externí odkaz:
https://doaj.org/article/70e7d767ad684d8c8219a03ce9e3ce6c
Publikováno v:
Clinical and Experimental Gastroenterology, Vol Volume 14, Pp 1-18 (2021)
Yi-Hua Wu,1 Jen-Wei Chou,1– 4 Hsiang-Chun Lai,5 Gin-Shen Su,1 Ken-Sheng Cheng,1,2 Tsung-Wei Chen6 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan; 2School of Medicin
Externí odkaz:
https://doaj.org/article/e7bae9bcacb444b49ef5ea1b1cd308eb
Publikováno v:
Clinical Case Reports, Vol 8, Iss 4, Pp 722-724 (2020)
Abstract Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable co
Externí odkaz:
https://doaj.org/article/2e84163f63374de38b2f6e12c0875ba3
Autor:
Smiley Annie GEORGE, Issam FRANCIS
Publikováno v:
Türk Patoloji Dergisi, Vol 35, Iss 3, Pp 221-227 (2019)
Objective: Medication resins such as Kayexalate and Sevelamer used in the setting of chronic kidney disease for the correction of hyperkalemia and hyperphosphatemia are associated with gastrointestinal mucosal injury. In this study we describe the cl
Externí odkaz:
https://doaj.org/article/4152089767ec4761b4d15361924ab21c
Publikováno v:
Journal of Renal and Hepatic Disorders, Vol 5, Iss 1 (2021)
The clinical features of corona virus disease 2019 (COVID-19) are variable, but the majority of patients experience mild flu-like symptoms. The cases of severe disease include complications such as progressive pneumonia, acute kidney injury, multi-or
Externí odkaz:
https://doaj.org/article/fca40cffa0c84c2d91fb69f6680b8678
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Gary Abuelo
Publikováno v:
Kidney International Reports, Vol 3, Iss 1, Pp 47-55 (2018)
Severe hyperkalemia is a medical emergency that can cause lethal arrhythmias. Successful management requires monitoring of the electrocardiogram and serum potassium concentrations, the prompt institution of therapies that work both synergistically an
Externí odkaz:
https://doaj.org/article/8d70c75818b94c98842646d87cbe2a43